• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物活性脂质的新冠病毒及其他类似感染的治疗方法。

Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.

作者信息

Das Undurti N

机构信息

UND Life Sciences, Battle Ground, WA, USA.

Department of Medicine, Omega Hospitals, Gachibowli, Hyderabad, India.

出版信息

Arch Med Sci. 2021 Apr 23;19(5):1327-1359. doi: 10.5114/aoms/135703. eCollection 2023.

DOI:10.5114/aoms/135703
PMID:37732033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10507771/
Abstract

COVID-19 is caused by SARS-CoV-2 infection. Epithelial and T, NK, and other immunocytes release bioactive lipids especially arachidonic acid (AA) in response to microbial infections to inactivate them and upregulate the immune system. COVID-19 (coronavirus) and other enveloped viruses including severe acute respiratory syndrome (SARS-CoV-1 of 2002-2003) and Middle East respiratory syndrome (MERS; 2012-ongoing) and hepatitis B and C (HBV and HCV) can be inactivated by AA, γ-linolenic acid (GLA, dihomo-GLA (DGLA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), which are precursors to several eicosanoids. Prostaglandin E1, lipoxin A4, resolvins, protectins and maresins enhance phagocytosis of macrophages and leukocytes to clear debris from the site(s) of infection and injury, enhance microbial clearance and wound healing to restore homeostasis. Bioactive lipids modulate the generation of M1 and M2 macrophages and the activity of other immunocytes. Mesenchymal and adipose tissue-derived stem cells secrete LXA4 and other bioactive lipids to bring about their beneficial actions in COVID-19. Bioactive lipids regulate vasomotor tone, inflammation, thrombosis, immune response, inactivate enveloped viruses, regulate T cell proliferation and secretion of cytokines, stem cell survival, proliferation and differentiation, and leukocyte and macrophage functions, JAK kinase activity and neutrophil extracellular traps and thus, have a critical role in COVID-19.

摘要

2019冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引起。上皮细胞以及T细胞、自然杀伤细胞(NK细胞)和其他免疫细胞在受到微生物感染时会释放生物活性脂质,尤其是花生四烯酸(AA),以使其失活并上调免疫系统。2019冠状病毒病(新冠病毒)和其他包膜病毒,包括严重急性呼吸综合征(2002 - 2003年的SARS-CoV-1)、中东呼吸综合征(MERS;2012年至今)以及乙型和丙型肝炎病毒(HBV和HCV)可被AA、γ-亚麻酸(GLA)、二高-γ-亚麻酸(DGLA)、二十碳五烯酸(EPA)、二十二碳六烯酸(DHA)灭活,这些都是几种类花生酸的前体。前列腺素E1、脂氧素A4、消退素、保护素和maresin可增强巨噬细胞和白细胞的吞噬作用,以清除感染和损伤部位的碎片,增强微生物清除和伤口愈合,从而恢复体内平衡。生物活性脂质可调节M1和M2巨噬细胞的生成以及其他免疫细胞的活性。间充质和脂肪组织来源的干细胞分泌脂氧素A4和其他生物活性脂质,从而在2019冠状病毒病中发挥有益作用。生物活性脂质调节血管舒缩张力、炎症、血栓形成、免疫反应,使包膜病毒失活,调节T细胞增殖和细胞因子分泌、干细胞存活、增殖和分化以及白细胞和巨噬细胞功能、JAK激酶活性和中性粒细胞胞外陷阱,因此在2019冠状病毒病中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/b1f3ea1ed906/AMS-19-5-135703-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/0b3d1daea1d3/AMS-19-5-135703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/beda09fd2b46/AMS-19-5-135703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/30d7fd722725/AMS-19-5-135703-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/0adb99936386/AMS-19-5-135703-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/78dd4cedf028/AMS-19-5-135703-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/cf6359b49106/AMS-19-5-135703-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/4b8ec3a1e28b/AMS-19-5-135703-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/6e0b016dcb43/AMS-19-5-135703-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/dcd1ebef9966/AMS-19-5-135703-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/6021404ba0ed/AMS-19-5-135703-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/b1f3ea1ed906/AMS-19-5-135703-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/0b3d1daea1d3/AMS-19-5-135703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/beda09fd2b46/AMS-19-5-135703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/30d7fd722725/AMS-19-5-135703-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/0adb99936386/AMS-19-5-135703-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/78dd4cedf028/AMS-19-5-135703-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/cf6359b49106/AMS-19-5-135703-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/4b8ec3a1e28b/AMS-19-5-135703-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/6e0b016dcb43/AMS-19-5-135703-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/dcd1ebef9966/AMS-19-5-135703-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/6021404ba0ed/AMS-19-5-135703-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c75c/10507771/b1f3ea1ed906/AMS-19-5-135703-g011.jpg

相似文献

1
Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections.基于生物活性脂质的新冠病毒及其他类似感染的治疗方法。
Arch Med Sci. 2021 Apr 23;19(5):1327-1359. doi: 10.5114/aoms/135703. eCollection 2023.
2
Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?生物活性脂质能否使冠状病毒(COVID-19)失活?
Arch Med Res. 2020 Apr;51(3):282-286. doi: 10.1016/j.arcmed.2020.03.004. Epub 2020 Mar 27.
3
Bioactive Lipids in COVID-19-Further Evidence.COVID-19 相关生物活性脂质:更多证据。
Arch Med Res. 2021 Jan;52(1):107-120. doi: 10.1016/j.arcmed.2020.09.006. Epub 2020 Sep 9.
4
"Cell Membrane Theory of Senescence" and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.《衰老的细胞膜理论》以及生物活性脂质在衰老、衰老相关疾病及其治疗意义中的作用。
Biomolecules. 2021 Feb 8;11(2):241. doi: 10.3390/biom11020241.
5
Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review.花生四烯酸及其他不饱和脂肪酸及其某些代谢产物作为内源性抗菌分子的功能:综述
J Adv Res. 2018 Jan 3;11:57-66. doi: 10.1016/j.jare.2018.01.001. eCollection 2018 May.
6
Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.必需脂肪酸及其代谢产物在炎症及其消退的病理生物学中的作用。
Biomolecules. 2021 Dec 14;11(12):1873. doi: 10.3390/biom11121873.
7
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.生物活性脂质作为间充质干细胞在COVID-19中有益作用的介质
Aging Dis. 2020 Jul 23;11(4):746-755. doi: 10.14336/AD.2020.0521. eCollection 2020 Jul.
8
Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.子痫前期中的细胞因子、血管生成和抗血管生成因子以及生物活性脂质。
Nutrition. 2015 Sep;31(9):1083-95. doi: 10.1016/j.nut.2015.03.013. Epub 2015 Apr 29.
9
Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?生物活性脂质花生四烯酸能预防和改善 COVID-19 吗?
Medicina (Kaunas). 2020 Aug 19;56(9):418. doi: 10.3390/medicina56090418.
10
Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.采用 UHPLC-MS/MS 技术对人类青少年和小鼠血浆中的炎症和促解决脂质介质进行定量分析。
Clin Chem Lab Med. 2021 Jul 12;59(11):1811-1823. doi: 10.1515/cclm-2021-0644. Print 2021 Oct 26.

引用本文的文献

1
Recent advances and future directions on GLA-producing organisms.产γ-亚麻酸(GLA)生物的最新进展与未来方向。
Front Bioeng Biotechnol. 2025 Jul 9;13:1567840. doi: 10.3389/fbioe.2025.1567840. eCollection 2025.
2
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses.二十碳五烯酸对寨卡病毒及其他包膜病毒的抗病毒活性。
Front Pharmacol. 2025 Apr 4;16:1564504. doi: 10.3389/fphar.2025.1564504. eCollection 2025.
3
Can essential fatty acids (EFAs) prevent and ameliorate post-COVID-19 long haul manifestations?

本文引用的文献

1
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.新冠病毒 Spike 蛋白锁闭结构中的游离脂肪酸结合口袋。
Science. 2020 Nov 6;370(6517):725-730. doi: 10.1126/science.abd3255. Epub 2020 Sep 21.
2
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
3
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
必需脂肪酸(EFAs)能否预防和改善新冠后长期症状?
Lipids Health Dis. 2024 Apr 19;23(1):112. doi: 10.1186/s12944-024-02090-4.
4
Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection.定制脂肽表面活性剂作为治疗新型冠状病毒感染的潜在有效药物。
Med Hypotheses. 2022 Oct;167:110948. doi: 10.1016/j.mehy.2022.110948. Epub 2022 Sep 17.
5
The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.多不饱和脂肪酸对 COVID 患者严重程度和死亡率的影响:系统评价。
Life Sci. 2022 Jun 15;299:120489. doi: 10.1016/j.lfs.2022.120489. Epub 2022 Mar 28.
6
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.COVID-19 和脂质。脂质紊乱和他汀类药物使用在 SARS-CoV-2 感染患者预后中的作用。
Lipids Health Dis. 2021 Oct 25;20(1):141. doi: 10.1186/s12944-021-01563-0.
纵向免疫分析揭示与 COVID-19 相关的关键髓系特征。
Sci Immunol. 2020 Sep 17;5(51). doi: 10.1126/sciimmunol.abd6197.
4
Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.I型干扰素缺乏:重症新冠患者的一种免疫学特征。
Signal Transduct Target Ther. 2020 Sep 14;5(1):198. doi: 10.1038/s41392-020-00306-4.
5
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.新冠病毒(COVID-19)中 Bcl-6 表达的滤泡辅助性 T 细胞和生发中心的缺失。
Cell. 2020 Oct 1;183(1):143-157.e13. doi: 10.1016/j.cell.2020.08.025. Epub 2020 Aug 19.
6
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.西替利嗪-法莫替丁双重阻断组胺受体可减轻 COVID-19 患者的肺部症状。
Pulm Pharmacol Ther. 2020 Aug;63:101942. doi: 10.1016/j.pupt.2020.101942. Epub 2020 Aug 29.
7
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?内皮细胞向间充质转化:新冠病毒感染后肺间质纤维化和血管闭塞的前兆?
Eur Respir J. 2020 Oct 15;56(4). doi: 10.1183/13993003.03167-2020. Print 2020 Oct.
8
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.法莫替丁对 COVID-19 住院患者临床结局的影响。
Am J Gastroenterol. 2020 Oct;115(10):1617-1623. doi: 10.14309/ajg.0000000000000832.
9
Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19.SARS-CoV-2 在粪便和尿液中的脱落及其在 COVID-19 人际传播和基于环境传播中的潜在作用。
Sci Total Environ. 2020 Dec 20;749:141364. doi: 10.1016/j.scitotenv.2020.141364. Epub 2020 Jul 31.
10
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.在重症新型冠状病毒肺炎和全身性过度炎症中使用玛弗利单抗进行粒细胞-巨噬细胞集落刺激因子阻断:一项单中心前瞻性队列研究。
Lancet Rheumatol. 2020 Aug;2(8):e465-e473. doi: 10.1016/S2665-9913(20)30170-3. Epub 2020 Jun 16.